MALARIA VACCINE
ebook ∣ All You Need to Know About its Discovery, Safety, Effectiveness and Countries Eligible to Receive it on WHOs Recommendation
By VANESSA JONES
Sign up to save your library
With an OverDrive account, you can save your favorite libraries for at-a-glance information about availability. Find out more about OverDrive accounts.
Share
Find this title in Libby, the library reading app by OverDrive.
Search for a digital library with this title
Title found at these libraries:
| Library Name | Distance |
|---|---|
| Loading... |
It is challenging to develop a malaria vaccine. It is technically challenging to create a vaccine against a parasite that has two hosts—mosquitoes and humans.
Additionally, several pharmaceutical firms have shown interest in creating a malaria vaccine.
The individuals who need a malaria vaccine the most reside in some of the world's poorest nations, despite the fact that travelers to afflicted areas may benefit from a malaria immunization. As a consequence, developing a vaccine is not financially rewarding.
More than 30 years of research went into the creation of Mosquirix, which was created in partnership between GlaxoSmithKline (GSK) and the Walter Reed Army Institute of Research in the US.
Given that both the antigen design and the adjuvant strategy were unique, this period seems acceptable.
Share
